Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
KING
Multicentre Prospective Observational Study for Identification of Determinants of Disability and Quality of Life in Patients With Gout.
1 other identifier
observational
450
1 country
1
Brief Summary
The study aims to identify which characteristics are associated with disability and poor quality of life in patients suffering from gout. This is a multicentre prospective observational study carried out in a cohort of Italian patients with gout. Subjects are randomly selected from a list of patients referred to each participant rheumatology clinic in the previous 2 years. Clinical evaluations are performed at baseline, at 6 and 12 months; data are retrieved about sociodemographic variables, life-styles, history of gout, comorbidities and patterns of treatment. At each visit patients complete questionnaires assessing disability and health-related quality of life. Preplanned analyses will be performed to investigate predictors of disability and poor quality of life in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 6, 2012
CompletedFirst Posted
Study publicly available on registry
March 9, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedMarch 12, 2013
March 1, 2013
1.9 years
March 6, 2012
March 9, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional disability
Health Assessment Questionnaire Disability Index (HAQ-DI)
1 year
Secondary Outcomes (1)
Health-related quality of life
1 year
Other Outcomes (2)
Short Form-36 Mental Summary Scale (SF-36 MCS)
1 year
Serum uric acid levels
6-12 months
Eligibility Criteria
Patients referring to rheumatologic clinics
You may qualify if:
- Clinical diagnosis of gout
- Must be able to understand questionnaires
You may not qualify if:
- Diagnosis not validated by rheumatologist
- Not able to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dept of Rheumatology - IRCCS San Matteo Foundation
Pavia, Pavia, 27100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carlo A Scirè, MD, PhD
Epidemiology Unit - Italian Society for Rheumatology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Coordinator of the Epidemiology Unit - SIR
Study Record Dates
First Submitted
March 6, 2012
First Posted
March 9, 2012
Study Start
April 1, 2011
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
March 12, 2013
Record last verified: 2013-03